Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Norsalsolinol

From Wikipedia, the free encyclopedia
Norsalsolinol
Skeletal formula of norsalsolinol
Space-filling model of the norsalsolinol molecule
Names
Preferred IUPAC name
1,2,3,4-Tetrahydroisoquinoline-6,7-diol
Other names
6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
UNII
  • InChI=1S/C9H11NO2/c11-8-3-6-1-2-10-5-7(6)4-9(8)12/h3-4,10-12H,1-2,5H2 ☒N
    Key: MBFUSGLXKQWVDW-UHFFFAOYSA-N ☒N
  • InChI=1/C9H11NO2/c11-8-3-6-1-2-10-5-7(6)4-9(8)12/h3-4,10-12H,1-2,5H2
    Key: MBFUSGLXKQWVDW-UHFFFAOYAF
  • C1CNCC2=CC(=C(C=C21)O)O
Properties
C9H11NO2
Molar mass165.189 g/mol
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
Neurotoxin
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

Norsalsolinol is atetrahydroisoquinoline that is produced naturally in the body through themetabolism ofdopamine.[1] It has been shown to be a selectivedopaminergic neurotoxin,[2][3][4] and has been suggested as a possible cause of neurodegenerative conditions such asParkinson's disease and the brain damage associated withalcoholism,[5][6] although evidence for a causal relationship is unclear.[7][8][9]

The related compound(R)-salsolinol, which has been shown to be a product of ethanol metabolism, stereospecifically induces behavioral sensitization and leads to excessive alcohol intake in rats.[10]

See also

[edit]

References

[edit]
  1. ^Maruyama W, Takahashi T, Minami M, Takahashi A, Dostert P, Nagatsu T, Naoi M (1993). "Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines".Advances in Neurology.60:224–30.PMID 8093579.
  2. ^Maruyama Y, Suzuki Y, Kazusaka A, Fujita S (May 2001)."Norsalsolinol uptake into secretory vesicles via vesicular monoamine transporter and its secretion by membrane depolarization or purinoceptor stimulation in PC12 cells".The Journal of Veterinary Medical Science.63 (5):493–7.doi:10.1292/jvms.63.493.PMID 11411492.
  3. ^Maruyama Y, Suzuki Y, Kazusaka A, Fujita S (June 2001). "Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter".Archives of Toxicology.75 (4):209–13.Bibcode:2001ArTox..75..209M.doi:10.1007/s002040000202.PMID 11482518.S2CID 38150947.
  4. ^Kobayashi H, Fukuhara K, Tada-Oikawa S, Yada Y, Hiraku Y, Murata M, Oikawa S (January 2009). "The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson's disease".Journal of Neurochemistry.108 (2):397–407.doi:10.1111/j.1471-4159.2008.05774.x.PMID 19012744.
  5. ^Dostert P, Strolin Benedetti M, Della Vedova F, Allievi C, La Croix R, Dordain G, Vernay D, Durif F (1993). "Dopamine-derived tetrahydroisoquinolines and Parkinson's disease".Advances in Neurology.60:218–23.PMID 8420138.
  6. ^Musshoff F, Daldrup T, Bonte W, Leitner A, Lesch OM (October 1997). "Salsolinol and norsalsolinol in human urine samples".Pharmacology Biochemistry and Behavior.58 (2):545–50.doi:10.1016/S0091-3057(97)00251-7.PMID 9300617.S2CID 76761.
  7. ^Musshoff F, Lachenmeier DW, Kroener L, Schmidt P, Dettmeyer R, Madea B (July 2003). "Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective".Cellular and Molecular Biology (Noisy-le-Grand, France).49 (5):837–49.PMID 14528920.
  8. ^Scholz J, Klingemann I, Moser A (April 2004)."Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease".Journal of Neurology, Neurosurgery, and Psychiatry.75 (4):634–6.doi:10.1136/jnnp.2003.010769.PMC 1739023.PMID 15026514.
  9. ^Musshoff F, Lachenmeier DW, Schmidt P, Dettmeyer R, Madea B (January 2005). "Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics".Alcoholism: Clinical and Experimental Research.29 (1):46–52.doi:10.1097/01.ALC.0000150011.81102.C2.PMID 15654290.
  10. ^"(R)-Salsolinol, a product of ethanol metabolism, stereospecifically induces behavioral sensitization and leads to excessive alcohol intake. | PubFacts.com".www.pubfacts.com. Retrieved2017-10-02.
Dopaminergic
Noradrenergic
Serotonergic
Unsorted
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=Norsalsolinol&oldid=1316586375"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp